tiprankstipranks
Trending News
More News >
Ascelia Pharma AB (DE:7ZA)
BERLIN:7ZA
Germany Market

Ascelia Pharma AB (7ZA) Financial Statements

Compare
2 Followers

Ascelia Pharma AB Financial Overview

Ascelia Pharma AB's market cap is currently €46.74M. The company's EPS TTM is €-0.0183046; its P/E ratio is ―; Ascelia Pharma AB is scheduled to report earnings on May 16, 2025, and the estimated EPS forecast is €>-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profitkr 0.00kr -1.05Mkr -3.89Mkr -8.72Mkr -825.00K
Operating Incomekr -67.77Mkr -110.91Mkr -147.01Mkr -137.95Mkr -93.43M
EBITDAkr -67.69Mkr -108.56Mkr -132.06Mkr -128.42Mkr -98.91M
Net Incomekr -80.03Mkr -109.29Mkr -131.22Mkr -125.90Mkr -98.70M
Balance Sheet
Cash & Short-Term Investmentskr 75.26Mkr 21.86Mkr 149.56Mkr 261.60Mkr 184.69M
Total Assetskr 140.92Mkr 87.07Mkr 218.57Mkr 333.49Mkr 255.37M
Total Debtkr 25.40Mkr 1.06Mkr 484.00Kkr 1.66Mkr 1.78M
Net Debtkr -49.86Mkr -20.80Mkr -149.07Mkr -259.94Mkr -182.91M
Total Liabilitieskr 61.98Mkr 12.74Mkr 37.71Mkr 25.66Mkr 19.32M
Stockholders' Equitykr 78.94Mkr 74.33Mkr 180.86Mkr 307.83Mkr 236.06M
Cash Flow
Free Cash Flowkr -62.84Mkr -126.79Mkr -125.33Mkr -116.60Mkr -85.92M
Operating Cash Flowkr -62.84Mkr -126.79Mkr -125.26Mkr -116.56Mkr -85.53M
Investing Cash Flowkr 0.00kr 46.00Kkr -65.00Kkr -38.00Kkr 75.99M
Financing Cash Flowkr 115.19Mkr -936.00Kkr -1.10Kkr 184.87Mkr 92.72M
Currency in SEK

Ascelia Pharma AB Earnings and Revenue History

Ascelia Pharma AB Debt to Assets

Ascelia Pharma AB Cash Flow

Ascelia Pharma AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis